KATIE JONES

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 709, H.R. 1270, Restoring Access to Medication Act). Lobby Congress to provide oversight of implementation of Public Law 113-195, the Sunscreen Innovation Act, intended to create a transparent and predictable review process for sunscreen ingredients. Lobby Congress on issues related to telemedicine. Advocate for strengthening and improving biomedical research, discovery and technological approval processes in the 21st Century Cures Initiative and Innovation for Healthier Americans.

Advocate against H.R. 2698, the Tanning Tax Repeal Act of 2015, to repeal excise tax on indoor tanning services. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 709, H.R. 1270, Restoring Access to Medication Act).

Advocate against legislation to repeal excise tax on indoor tanning services. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 709, H.R. 1270, Restoring Access to Medication Act).

Advocate against H.R. 2698, the Tanning Tax Repeal Act of 2015, to repeal excise tax on indoor tanning services. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 709, H.R. 1270, Restoring Access to Medication Act).

Advocate against H.R. 2698, the Tanning Tax Repeal Act of 2015, to repeal excise tax on indoor tanning services. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 709, H.R. 1270, Restoring Access to Medication Act).

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 709, H.R. 1270, Restoring Access to Medication Act). Lobby Congress to provide oversight of implementation of Public Law 113-195, the Sunscreen Innovation Act, intended to create a transparent and predictable review process for sunscreen ingredients. Lobby Congress on issues related to telemedicine. Advocate for strengthening and improving biomedical research, discovery and technological approval processes in the 21st Century Cures Initiative and Innovation for Healthier Americans.

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Support S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act. Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient-specific prescription. Lobby Congress to provide oversight of implementation of Public Law 113-195, the Sunscreen Innovation Act, intended to create a transparent and predictable review process for sunscreen ingredients. Advocate for OMB to release FDA proposed rules that would provide further oversight for indoor tanning devices. Lobby Congress on issues related to telemedicine. Oppose H.R. 2519, the Audiology Patient Choice Act of 2015. Support legislation to establish a federal standard for the provision of telemedicine (H.R. 691, the Telehealth Modernization Act).

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Support S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act. Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription. Lobby Congress to provide oversight of implementation of Public Law 113-195, the Sunscreen Innovation Act, intended to create a transparent and predictable review process for sunscreen ingredients. Advocate for OMB to release FDA proposed rules that would provide further oversight for indoor tanning devices. Lobby Congress on issues related to telemedicine. Advocate for strengthening and improving biomedical research, discovery and technological approval processes in the 21st Century Cures Initiative and Innovation for Healthier Americans. Support H.R. 293, the Protect Continuing Physician Education and Patient Care Act. Oppose H.R. 2519, the Audiology Patient Choice Act of 2015. Support legislation to establish a federal standard for the provision of telemedicine (H.R. 691, the Telehealth Modernization Act).

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Support S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act. Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription. Advocate for OMB to release FDA proposed rules that would provide further oversight for indoor tanning devices. Lobby Congress on issues related to telemedicine. Support legislation to establish a federal standard for the provision of telemedicine (H.R. 691, the Telehealth Modernization Act).

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141, H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (H.R. 2, Medicare Access and CHIP Reauthorization Act ). Lobby in support of legislation to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. (H.R. 2 Medicare Access and CHIP Reauthorization Act ). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on impact of Health Information Technology. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act) Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act and (H.R. 2652), the Protecting Patients and Physicians against Coding Act). Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act and H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act). Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act, (H.R. 2652), the Protecting Patients and Physicians against Coding Act and (H.R. 3018), the Code FLEX Act. Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions. Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141, H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (H.R. 2, Medicare Access and CHIP Reauthorization Act ). Lobby in support of legislation to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. (H.R. 2 Medicare Access and CHIP Reauthorization Act ). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on impact of Health Information Technology. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act) Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act and (H.R. 2652), the Protecting Patients and Physicians against Coding Act). Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions.

Advocate for legislation to enact medical liability reforms. Support inclusion of standard of care provisions in H.R. 2, Medicare Access and CHIP Reauthorization Act.

Advocate for legislation to enact medical liability reforms. Support inclusion of standard of care provisions in H.R. 2, Medicare Access and CHIP Reauthorization Act.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141, H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (H.R. 2, Medicare Access and CHIP Reauthorization Act ). Lobby in support of legislation to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. (H.R. 2 Medicare Access and CHIP Reauthorization Act ). Lobby in support of increased transparency and adequate response time from CMS when setting values for misvalued codes. Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on impact of Health Information Technology. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act) Advocate for EHR interoperability with clinical data registries for quality improvement purposes. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Advocate regarding CMS global payment proposal, data registry issues, electronic health record and Medicare policies in 21st Century cures initiative.

Support H.R. 6, the 21st Century Cures Act to strengthen and improve the discovery, development and delivery of treatments and cures Advocate for NIH and FDA reforms in the Innovation for Healthier Americans initiative. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request -- Public Law 114-113 (H.R. 2029),the Consolidated Appropriations Act, 2016). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act) Raise awareness of research and access issues related to vitiligo.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act and H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act). Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act, (H.R. 2652), the Protecting Patients and Physicians against Coding Act and (H.R. 3018), the Code FLEX Act. Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions. Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141, H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (H.R. 2, Medicare Access and CHIP Reauthorization Act ). Lobby in support of legislation to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. (H.R. 2 Medicare Access and CHIP Reauthorization Act ). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on impact of Health Information Technology. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act) Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act and (H.R. 2652), the Protecting Patients and Physicians against Coding Act). Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act and H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act). Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act, (H.R. 2652), the Protecting Patients and Physicians against Coding Act and (H.R. 3018), the Code FLEX Act. Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions. Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141, H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (H.R. 2, Medicare Access and CHIP Reauthorization Act ). Lobby in support of legislation to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. (H.R. 2 Medicare Access and CHIP Reauthorization Act ). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on impact of Health Information Technology. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act) Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act and (H.R. 2652), the Protecting Patients and Physicians against Coding Act). Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions.

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Support S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act. Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient-specific prescription. Lobby Congress to provide oversight of implementation of Public Law 113-195, the Sunscreen Innovation Act, intended to create a transparent and predictable review process for sunscreen ingredients. Advocate for OMB to release FDA proposed rules that would provide further oversight for indoor tanning devices. Lobby Congress on issues related to telemedicine. Oppose H.R. 2519, the Audiology Patient Choice Act of 2015. Support legislation to establish a federal standard for the provision of telemedicine (H.R. 691, the Telehealth Modernization Act).

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Support S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act. Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription. Lobby Congress to provide oversight of implementation of Public Law 113-195, the Sunscreen Innovation Act, intended to create a transparent and predictable review process for sunscreen ingredients. Advocate for OMB to release FDA proposed rules that would provide further oversight for indoor tanning devices. Lobby Congress on issues related to telemedicine. Advocate for strengthening and improving biomedical research, discovery and technological approval processes in the 21st Century Cures Initiative and Innovation for Healthier Americans. Support H.R. 293, the Protect Continuing Physician Education and Patient Care Act. Oppose H.R. 2519, the Audiology Patient Choice Act of 2015. Support legislation to establish a federal standard for the provision of telemedicine (H.R. 691, the Telehealth Modernization Act).

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act and H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act). Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act, (H.R. 2652), the Protecting Patients and Physicians against Coding Act and (H.R. 3018), the Code FLEX Act. Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions. Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015). Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act, H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act), H.R. 3940, the Meaningful Use Hardship Relief Act of 2015 and S. 2425, Patient Access and Medicare Protection Act. Advocate for EHR interoperability and enhancements to the federal certification system for health information technology (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015 and S. 289, the American Cures Act. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act and H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act). Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act, (H.R. 2652), the Protecting Patients and Physicians against Coding Act and (H.R. 3018), the Code FLEX Act. Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions. Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141, H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (H.R. 2, Medicare Access and CHIP Reauthorization Act ). Lobby in support of legislation to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. (H.R. 2 Medicare Access and CHIP Reauthorization Act ). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on impact of Health Information Technology. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act) Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act and (H.R. 2652), the Protecting Patients and Physicians against Coding Act). Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions.

Advocate against H.R. 2698, the Tanning Tax Repeal Act of 2015, to repeal excise tax on indoor tanning services. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 709, H.R. 1270, Restoring Access to Medication Act).

Advocate against H.R. 2698, the Tanning Tax Repeal Act of 2015, to repeal excise tax on indoor tanning services. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 709, H.R. 1270, Restoring Access to Medication Act).

Advocate against H.R. 2698, the Tanning Tax Repeal Act of 2015, to repeal excise tax on indoor tanning services. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 709, H.R. 1270, Restoring Access to Medication Act).

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141, H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (H.R. 2, Medicare Access and CHIP Reauthorization Act ). Lobby in support of legislation to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. (H.R. 2 Medicare Access and CHIP Reauthorization Act ). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on impact of Health Information Technology. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act) Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act and (H.R. 2652), the Protecting Patients and Physicians against Coding Act). Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015). Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act, H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act), H.R. 3940, the Meaningful Use Hardship Relief Act of 2015 and S. 2425, Patient Access and Medicare Protection Act. Advocate for EHR interoperability and enhancements to the federal certification system for health information technology (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015 and S. 289, the American Cures Act. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act and H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act). Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act, (H.R. 2652), the Protecting Patients and Physicians against Coding Act and (H.R. 3018), the Code FLEX Act. Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions. Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141, H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (H.R. 2, Medicare Access and CHIP Reauthorization Act ). Lobby in support of legislation to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. (H.R. 2 Medicare Access and CHIP Reauthorization Act ). Lobby in support of increased transparency and adequate response time from CMS when setting values for misvalued codes. Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on impact of Health Information Technology. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act) Advocate for EHR interoperability with clinical data registries for quality improvement purposes. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Advocate regarding CMS global payment proposal, data registry issues, electronic health record and Medicare policies in 21st Century cures initiative.

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Support S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act. Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription. Lobby Congress to provide oversight of implementation of Public Law 113-195, the Sunscreen Innovation Act, intended to create a transparent and predictable review process for sunscreen ingredients. Advocate for OMB to release FDA proposed rules that would provide further oversight for indoor tanning devices. Lobby Congress on issues related to telemedicine. Advocate for strengthening and improving biomedical research, discovery and technological approval processes in the 21st Century Cures Initiative and Innovation for Healthier Americans. Support H.R. 293, the Protect Continuing Physician Education and Patient Care Act. Oppose H.R. 2519, the Audiology Patient Choice Act of 2015. Support legislation to establish a federal standard for the provision of telemedicine (H.R. 691, the Telehealth Modernization Act).

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act and H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act). Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act, (H.R. 2652), the Protecting Patients and Physicians against Coding Act and (H.R. 3018), the Code FLEX Act. Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions. Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015). Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act, H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act), H.R. 3940, the Meaningful Use Hardship Relief Act of 2015 and S. 2425, Patient Access and Medicare Protection Act. Advocate for EHR interoperability and enhancements to the federal certification system for health information technology (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015 and S. 289, the American Cures Act. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act and H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act). Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act, (H.R. 2652), the Protecting Patients and Physicians against Coding Act and (H.R. 3018), the Code FLEX Act. Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions. Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015). Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act, H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act), H.R. 3940, the Meaningful Use Hardship Relief Act of 2015 and S. 2425, Patient Access and Medicare Protection Act. Advocate for EHR interoperability and enhancements to the federal certification system for health information technology (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015 and S. 289, the American Cures Act. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015). Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act, H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act), H.R. 3940, the Meaningful Use Hardship Relief Act of 2015 and S. 2425, Patient Access and Medicare Protection Act. Advocate for EHR interoperability and enhancements to the federal certification system for health information technology (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015 and S. 289, the American Cures Act. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act.

Support H.R. 6, the 21st Century Cures Act to strengthen and improve the discovery, development and delivery of treatments and cures Advocate for NIH and FDA reforms in the Innovation for Healthier Americans initiative. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request -- Public Law 114-113 (H.R. 2029),the Consolidated Appropriations Act, 2016). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act) Raise awareness of research and access issues related to vitiligo.

Advocate for strengthening and improving biomedical research, discovery and technological approval processes in the 21st Century Cures Initiative and Innovation for Healthier Americans. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act) Advocate for reforms to NIH and FDA.

Support H.R. 6, the 21st Century Cures Act to strengthen and improve the discovery, development and delivery of treatments and cures Advocate for NIH and FDA reforms in the Innovation for Healthier Americans initiative. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act)

Support H.R. 6, the 21st Century Cures Act to strengthen and improve biomedical research, discovery and technological approval processes Advocate for NIH and FDA reforms in the Innovation for Healthier Americans initiative. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act) Advocate for reforms to NIH and FDA.

Support H.R. 6, the 21st Century Cures Act to strengthen and improve the discovery, development and delivery of treatments and cures Advocate for NIH and FDA reforms in the Innovation for Healthier Americans initiative. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act)

Support H.R. 6, the 21st Century Cures Act to strengthen and improve biomedical research, discovery and technological approval processes Advocate for NIH and FDA reforms in the Innovation for Healthier Americans initiative. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act) Advocate for reforms to NIH and FDA.

Support H.R. 6, the 21st Century Cures Act to strengthen and improve the discovery, development and delivery of treatments and cures Advocate for NIH and FDA reforms in the Innovation for Healthier Americans initiative. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request -- Public Law 114-113 (H.R. 2029),the Consolidated Appropriations Act, 2016). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act) Raise awareness of research and access issues related to vitiligo.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141, H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (H.R. 2, Medicare Access and CHIP Reauthorization Act ). Lobby in support of legislation to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. (H.R. 2 Medicare Access and CHIP Reauthorization Act ). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on impact of Health Information Technology. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act) Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act and (H.R. 2652), the Protecting Patients and Physicians against Coding Act). Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act and H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act). Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act, (H.R. 2652), the Protecting Patients and Physicians against Coding Act and (H.R. 3018), the Code FLEX Act. Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions. Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Support S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act. Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription. Lobby Congress to provide oversight of implementation of Public Law 113-195, the Sunscreen Innovation Act, intended to create a transparent and predictable review process for sunscreen ingredients. Advocate for OMB to release FDA proposed rules that would provide further oversight for indoor tanning devices. Lobby Congress on issues related to telemedicine. Advocate for strengthening and improving biomedical research, discovery and technological approval processes in the 21st Century Cures Initiative and Innovation for Healthier Americans. Support H.R. 293, the Protect Continuing Physician Education and Patient Care Act. Oppose H.R. 2519, the Audiology Patient Choice Act of 2015. Support legislation to establish a federal standard for the provision of telemedicine (H.R. 691, the Telehealth Modernization Act).

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Support S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act. Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription. Advocate for OMB to release FDA proposed rules that would provide further oversight for indoor tanning devices. Lobby Congress on issues related to telemedicine. Support legislation to establish a federal standard for the provision of telemedicine (H.R. 691, the Telehealth Modernization Act).

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Support S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act. Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient-specific prescription. Lobby Congress to provide oversight of implementation of Public Law 113-195, the Sunscreen Innovation Act, intended to create a transparent and predictable review process for sunscreen ingredients. Advocate for OMB to release FDA proposed rules that would provide further oversight for indoor tanning devices. Lobby Congress on issues related to telemedicine. Oppose H.R. 2519, the Audiology Patient Choice Act of 2015. Support legislation to establish a federal standard for the provision of telemedicine (H.R. 691, the Telehealth Modernization Act).

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act and H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act). Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act, (H.R. 2652), the Protecting Patients and Physicians against Coding Act and (H.R. 3018), the Code FLEX Act. Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions. Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015). Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act, H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act), H.R. 3940, the Meaningful Use Hardship Relief Act of 2015 and S. 2425, Patient Access and Medicare Protection Act. Advocate for EHR interoperability and enhancements to the federal certification system for health information technology (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015 and S. 289, the American Cures Act. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141, H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (H.R. 2, Medicare Access and CHIP Reauthorization Act ). Lobby in support of legislation to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. (H.R. 2 Medicare Access and CHIP Reauthorization Act ). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on impact of Health Information Technology. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act) Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act and (H.R. 2652), the Protecting Patients and Physicians against Coding Act). Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141, H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (H.R. 2, Medicare Access and CHIP Reauthorization Act ). Lobby in support of legislation to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. (H.R. 2 Medicare Access and CHIP Reauthorization Act ). Lobby in support of increased transparency and adequate response time from CMS when setting values for misvalued codes. Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on impact of Health Information Technology. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act) Advocate for EHR interoperability with clinical data registries for quality improvement purposes. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Advocate regarding CMS global payment proposal, data registry issues, electronic health record and Medicare policies in 21st Century cures initiative.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act and H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act). Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act, (H.R. 2652), the Protecting Patients and Physicians against Coding Act and (H.R. 3018), the Code FLEX Act. Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions. Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015). Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act, H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act), H.R. 3940, the Meaningful Use Hardship Relief Act of 2015 and S. 2425, Patient Access and Medicare Protection Act. Advocate for EHR interoperability and enhancements to the federal certification system for health information technology (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015 and S. 289, the American Cures Act. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act.

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Support S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act. Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription. Advocate for OMB to release FDA proposed rules that would provide further oversight for indoor tanning devices. Lobby Congress on issues related to telemedicine. Support legislation to establish a federal standard for the provision of telemedicine (H.R. 691, the Telehealth Modernization Act).

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Support S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act. Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient-specific prescription. Lobby Congress to provide oversight of implementation of Public Law 113-195, the Sunscreen Innovation Act, intended to create a transparent and predictable review process for sunscreen ingredients. Advocate for OMB to release FDA proposed rules that would provide further oversight for indoor tanning devices. Lobby Congress on issues related to telemedicine. Oppose H.R. 2519, the Audiology Patient Choice Act of 2015. Support legislation to establish a federal standard for the provision of telemedicine (H.R. 691, the Telehealth Modernization Act).

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Support S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act. Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription. Lobby Congress to provide oversight of implementation of Public Law 113-195, the Sunscreen Innovation Act, intended to create a transparent and predictable review process for sunscreen ingredients. Advocate for OMB to release FDA proposed rules that would provide further oversight for indoor tanning devices. Lobby Congress on issues related to telemedicine. Advocate for strengthening and improving biomedical research, discovery and technological approval processes in the 21st Century Cures Initiative and Innovation for Healthier Americans. Support H.R. 293, the Protect Continuing Physician Education and Patient Care Act. Oppose H.R. 2519, the Audiology Patient Choice Act of 2015. Support legislation to establish a federal standard for the provision of telemedicine (H.R. 691, the Telehealth Modernization Act).

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015). Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act, H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act), H.R. 3940, the Meaningful Use Hardship Relief Act of 2015 and S. 2425, Patient Access and Medicare Protection Act. Advocate for EHR interoperability and enhancements to the federal certification system for health information technology (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015 and S. 289, the American Cures Act. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act and H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act). Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act, (H.R. 2652), the Protecting Patients and Physicians against Coding Act and (H.R. 3018), the Code FLEX Act. Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions. Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141, H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (H.R. 2, Medicare Access and CHIP Reauthorization Act ). Lobby in support of legislation to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. (H.R. 2 Medicare Access and CHIP Reauthorization Act ). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on impact of Health Information Technology. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act) Advocate for EHR interoperability with clinical data registries for quality improvement purposes in the 21st Century Cures Act (H.R. 6). Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support for legislation to enhance Medicare beneficiaries access to the physician of their choice (H.R. 1650, the Medicare Patient Empowerment Act). Support legislation to protect physicians and provide flexibility during the ICD-10 transition (H.R. 2126), the Cutting Costly Codes Act, (H.R. 2247), the Increasing Clarity for Doctors by Transitioning Effectively Now (ICD-TEN) Act and (H.R. 2652), the Protecting Patients and Physicians against Coding Act). Advocate for changes that would improve health outcomes for Medicare patients with chronic conditions.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141, H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (H.R. 2, Medicare Access and CHIP Reauthorization Act ). Lobby in support of legislation to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. (H.R. 2 Medicare Access and CHIP Reauthorization Act ). Lobby in support of increased transparency and adequate response time from CMS when setting values for misvalued codes. Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on impact of Health Information Technology. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act) Advocate for EHR interoperability with clinical data registries for quality improvement purposes. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Advocate regarding CMS global payment proposal, data registry issues, electronic health record and Medicare policies in 21st Century cures initiative.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015). Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act, H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act), H.R. 3940, the Meaningful Use Hardship Relief Act of 2015 and S. 2425, Patient Access and Medicare Protection Act. Advocate for EHR interoperability and enhancements to the federal certification system for health information technology (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015 and S. 289, the American Cures Act. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015). Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act, H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act), H.R. 3940, the Meaningful Use Hardship Relief Act of 2015 and S. 2425, Patient Access and Medicare Protection Act. Advocate for EHR interoperability and enhancements to the federal certification system for health information technology (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015 and S. 289, the American Cures Act. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015). Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act, H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act), H.R. 3940, the Meaningful Use Hardship Relief Act of 2015 and S. 2425, Patient Access and Medicare Protection Act. Advocate for EHR interoperability and enhancements to the federal certification system for health information technology (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015 and S. 289, the American Cures Act. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act.

Support H.R. 6, the 21st Century Cures Act to strengthen and improve biomedical research, discovery and technological approval processes Advocate for NIH and FDA reforms in the Innovation for Healthier Americans initiative. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act) Advocate for reforms to NIH and FDA.

Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015). Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on improvements to Health Information Technology implementation. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to provide more flexibility in the Meaningful Use program and extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act, H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act), H.R. 3940, the Meaningful Use Hardship Relief Act of 2015 and S. 2425, Patient Access and Medicare Protection Act. Advocate for EHR interoperability and enhancements to the federal certification system for health information technology (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015 and S. 289, the American Cures Act. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Support legislation to improve transparency and due process in the Medicare RAC audit and appeals process (H.R. 2568, Fair Medical Audits Act). Support legislation to reduce Medicare fraud and improve access to Death Master File, S. 1073, the Stopping Improper Payments to Deceased People Act.

Advocate for strengthening and improving biomedical research, discovery and technological approval processes in the 21st Century Cures Initiative and Innovation for Healthier Americans. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act) Advocate for reforms to NIH and FDA.

Support H.R. 6, the 21st Century Cures Act to strengthen and improve the discovery, development and delivery of treatments and cures Advocate for NIH and FDA reforms in the Innovation for Healthier Americans initiative. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act)

Support H.R. 6, the 21st Century Cures Act to strengthen and improve the discovery, development and delivery of treatments and cures Advocate for NIH and FDA reforms in the Innovation for Healthier Americans initiative. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request -- Public Law 114-113 (H.R. 2029),the Consolidated Appropriations Act, 2016). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act) Raise awareness of research and access issues related to vitiligo.

Support H.R. 6, the 21st Century Cures Act to strengthen and improve the discovery, development and delivery of treatments and cures Advocate for NIH and FDA reforms in the Innovation for Healthier Americans initiative. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act)

Support H.R. 6, the 21st Century Cures Act to strengthen and improve biomedical research, discovery and technological approval processes Advocate for NIH and FDA reforms in the Innovation for Healthier Americans initiative. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act) Advocate for reforms to NIH and FDA.

Advocate for strengthening and improving biomedical research, discovery and technological approval processes in the 21st Century Cures Initiative and Innovation for Healthier Americans. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act) Advocate for reforms to NIH and FDA.

Support H.R. 6, the 21st Century Cures Act to strengthen and improve the discovery, development and delivery of treatments and cures Advocate for NIH and FDA reforms in the Innovation for Healthier Americans initiative. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request -- Public Law 114-113 (H.R. 2029),the Consolidated Appropriations Act, 2016). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act) Raise awareness of research and access issues related to vitiligo.

Advocate against H.R. 2698, the Tanning Tax Repeal Act of 2015, to repeal excise tax on indoor tanning services. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 709, H.R. 1270, Restoring Access to Medication Act).

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 709, H.R. 1270, Restoring Access to Medication Act). Lobby Congress to provide oversight of implementation of Public Law 113-195, the Sunscreen Innovation Act, intended to create a transparent and predictable review process for sunscreen ingredients. Lobby Congress on issues related to telemedicine. Advocate for strengthening and improving biomedical research, discovery and technological approval processes in the 21st Century Cures Initiative and Innovation for Healthier Americans.

Advocate against H.R. 2698, the Tanning Tax Repeal Act of 2015, to repeal excise tax on indoor tanning services. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 709, H.R. 1270, Restoring Access to Medication Act).

Advocate against H.R. 2698, the Tanning Tax Repeal Act of 2015, to repeal excise tax on indoor tanning services. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 709, H.R. 1270, Restoring Access to Medication Act).

Advocate against legislation to repeal excise tax on indoor tanning services. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 709, H.R. 1270, Restoring Access to Medication Act).

Support legislation to eliminate the Independent Payment Advisory Board (S.351, H.R. 351, Protecting Seniors' Access to Medicare Act of 2013). Support legislation to increase residency slots for Graduate Medical Education (H.R. 1201, Training Tomorrow's Doctors Today Act).Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (S.2000/H.R. 4015; SGR Repeal and Medicare Provider Payment Modernization Act of 2014 ). Lobby in support of a cap on the amount CMS can decrease payment to physician services in a given year. (related provision included in S.2000/H.R. 4015; SGR Repeal and Medicare Provider Payment Modernization Act of 2014 and H.R. 4302, Protecting Access to Medicare Act). Lobby Congress in opposition to proposed legislation to repeal in-office ancillary and physician services for anatomic pathology services (H.R. 2914, Promoting Integrity in Medicare Act of 2013, FY 15 President's Budget). Lobby Congress on impact of Health Information Technology. Lobby Congress to stop sequestration cuts to Medicare physician payments (Bipartisan Budget Act of 2013). Lobby in support of increased transparency and adequate response time from CMS when setting values for misvalued codes. Oppose legislation allowing non-physician providers direct access to Medicare patients without a referral (H.R. 5304, Audiology Patient Choice Act of 2014). Advocate on issues related to waste, fraud and abuse in Medicare.

Support legislation to eliminate the Independent Payment Advisory Board (S.351, H.R. 351, Protecting Seniors' Access to Medicare Act of 2013). Support legislation to increase residency slots for Graduate Medical Education (H.R. 1201, Training Tomorrow's Doctors Today Act).Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (S.2000/H.R. 4015; SGR Repeal and Medicare Provider Payment Modernization Act of 2014 ). Lobby in support of a cap on the amount CMS can decrease payment to physician services in a given year. (related provision included in S.2000/H.R. 4015; SGR Repeal and Medicare Provider Payment Modernization Act of 2014 and H.R. 4302, Protecting Access to Medicare Act). Lobby Congress in opposition to proposed legislation to repeal in-office ancillary and physician services for anatomic pathology services (H.R. 2914, Promoting Integrity in Medicare Act of 2013, FY 15 President's Budget). Lobby Congress on impact of Health Information Technology. Support legislation to reform the Medicare and Medicaid Electronic Health Records Incentive Program (H.R. 1331, Electronic Health Records Improvement Act). Lobby Congress to stop sequestration cuts to Medicare physician payments (Bipartisan Budget Act of 2013). Oppose SGR patch legislation (H.R. 4302, Protecting Access to Medicare Act). Lobby in support of increased transparency and adequate response time from CMS when setting values for misvalued codes.

Support legislation to eliminate the Independent Payment Advisory Board (S.351, H.R. 351, Protecting Seniors' Access to Medicare Act of 2013). Support legislation to increase residency slots for Graduate Medical Education (H.R. 1201, Training Tomorrow's Doctors Today Act). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (S.2000/H.R. 4015; SGR Repeal and Medicare Provider Payment Modernization Act of 2014 ). Lobby in support of a cap on the amount CMS can decrease payment to physician services in a given year. (related provision included in S.2000/H.R. 4015; SGR Repeal and Medicare Provider Payment Modernization Act of 2014 and H.R. 4302, Protecting Access to Medicare Act). Lobby Congress in opposition to proposed legislation to repeal in-office ancillary and physician services for anatomic pathology services (H.R. 2914, Promoting Integrity in Medicare Act of 2013, FY 15 President's Budget). Lobby Congress on impact of Health Information Technology. Lobby Congress to stop sequestration cuts to Medicare physician payments (Bipartisan Budget Act of 2013). Lobby in support of increased transparency and adequate response time from CMS when setting values for misvalued codes. Oppose legislation allowing non-physician providers direct access to Medicare patients without a referral (H.R. 5304, Audiology Patient Choice Act of 2014). Advocate on issues related to waste, fraud and abuse in Medicare. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 5481, Flexibility in Health IT Reporting (Flex-IT) Act) Lobby Congress to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2552/H.R. 4998, Medicare Advantage Participant Bill of Rights Act of 2014). Lobby Congress on issues related to telemedicine (H.R. 5380, the Medicare Telehealth Parity Act).

Support legislation to eliminate the Independent Payment Advisory Board (S.351, H.R. 351, Protecting Seniors' Access to Medicare Act of 2013). Support legislation to increase residency slots for Graduate Medical Education (H.R. 1201, Training Tomorrow's Doctors Today Act).Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (S.2000/H.R. 4015; SGR Repeal and Medicare Provider Payment Modernization Act of 2014 ). Lobby in support of a cap on the amount CMS can decrease payment to physician services in a given year. (related provision included in S.2000/H.R. 4015; SGR Repeal and Medicare Provider Payment Modernization Act of 2014 and H.R. 4302, Protecting Access to Medicare Act). Lobby Congress in opposition to proposed legislation to repeal in-office ancillary and physician services for anatomic pathology services (H.R. 2914, Promoting Integrity in Medicare Act of 2013, FY 15 President's Budget). Lobby Congress on impact of Health Information Technology. Support legislation to reform the Medicare and Medicaid Electronic Health Records Incentive Program (H.R. 1331, Electronic Health Records Improvement Act). Advocate against legislation to grant audiologists unlimited direct access to Medicare patients without a physician referral (S. 2046, H.R. 4035, Access to Hearing Healthcare Act of 2014). Lobby Congress to stop sequestration cuts to Medicare physician payments (Bipartisan Budget Act of 2013). Oppose SGR patch legislation (H.R. 4302, Protecting Access to Medicare Act).

Support legislation to eliminate the Independent Payment Advisory Board (S.351, H.R. 351, Protecting Seniors' Access to Medicare Act of 2013). Support legislation to increase residency slots for Graduate Medical Education (H.R. 1201, Training Tomorrow's Doctors Today Act). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (S.2000/H.R. 4015; SGR Repeal and Medicare Provider Payment Modernization Act of 2014 ). Lobby in support of a cap on the amount CMS can decrease payment to physician services in a given year. (related provision included in S.2000/H.R. 4015; SGR Repeal and Medicare Provider Payment Modernization Act of 2014 and H.R. 4302, Protecting Access to Medicare Act). Lobby Congress in opposition to proposed legislation to repeal in-office ancillary and physician services for anatomic pathology services (H.R. 2914, Promoting Integrity in Medicare Act of 2013, FY 15 President's Budget). Lobby Congress on impact of Health Information Technology. Lobby Congress to stop sequestration cuts to Medicare physician payments (Bipartisan Budget Act of 2013). Lobby in support of increased transparency and adequate response time from CMS when setting values for misvalued codes. Oppose legislation allowing non-physician providers direct access to Medicare patients without a referral (H.R. 5304, Audiology Patient Choice Act of 2014). Advocate on issues related to waste, fraud and abuse in Medicare. Advocate regarding use and release of Medicare data regarding services provide by physicians. Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage networks (S. 2552/H.R. 4998, Medicare Advantage Participant Bill of Rights Act of 2014). Lobby Congress on issues related to telemedicine (H.R. 5380, the Medicare Telehealth Parity Act).

Support legislation to eliminate the Independent Payment Advisory Board (S.351, H.R. 351, Protecting Seniors' Access to Medicare Act of 2013). Support legislation to increase residency slots for Graduate Medical Education (H.R. 1201, Training Tomorrow's Doctors Today Act).Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (S.2000/H.R. 4015; SGR Repeal and Medicare Provider Payment Modernization Act of 2014 ). Lobby in support of a cap on the amount CMS can decrease payment to physician services in a given year. (related provision included in S.2000/H.R. 4015; SGR Repeal and Medicare Provider Payment Modernization Act of 2014 and H.R. 4302, Protecting Access to Medicare Act). Lobby Congress in opposition to proposed legislation to repeal in-office ancillary and physician services for anatomic pathology services (H.R. 2914, Promoting Integrity in Medicare Act of 2013, FY 15 President's Budget). Lobby Congress on impact of Health Information Technology. Support legislation to reform the Medicare and Medicaid Electronic Health Records Incentive Program (H.R. 1331, Electronic Health Records Improvement Act). Advocate against legislation to grant audiologists unlimited direct access to Medicare patients without a physician referral (S. 2046, H.R. 4035, Access to Hearing Healthcare Act of 2014). Lobby Congress to stop sequestration cuts to Medicare physician payments (Bipartisan Budget Act of 2013). Oppose SGR patch legislation (H.R. 4302, Protecting Access to Medicare Act).

Support legislation to eliminate the Independent Payment Advisory Board (S.351, H.R. 351, Protecting Seniors' Access to Medicare Act of 2013). Support legislation to increase residency slots for Graduate Medical Education (H.R. 1201, Training Tomorrow's Doctors Today Act).Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (S.2000/H.R. 4015; SGR Repeal and Medicare Provider Payment Modernization Act of 2014 ). Lobby in support of a cap on the amount CMS can decrease payment to physician services in a given year. (related provision included in S.2000/H.R. 4015; SGR Repeal and Medicare Provider Payment Modernization Act of 2014 and H.R. 4302, Protecting Access to Medicare Act). Lobby Congress in opposition to proposed legislation to repeal in-office ancillary and physician services for anatomic pathology services (H.R. 2914, Promoting Integrity in Medicare Act of 2013, FY 15 President's Budget). Lobby Congress on impact of Health Information Technology. Support legislation to reform the Medicare and Medicaid Electronic Health Records Incentive Program (H.R. 1331, Electronic Health Records Improvement Act). Lobby Congress to stop sequestration cuts to Medicare physician payments (Bipartisan Budget Act of 2013). Oppose SGR patch legislation (H.R. 4302, Protecting Access to Medicare Act). Lobby in support of increased transparency and adequate response time from CMS when setting values for misvalued codes.

Advocate on behalf of provisions for inclusion in the 21st Century Cures Initiative. Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 460, Patients' Access to Treatments Act of 2013). Advocate for truth in advertising for health care providers (H.R. 1427, Truth in Healthcare Marketing Act of 2013). Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription (H.R. 3204, Drug Quality and Security Act/Public Law No: 113-54). Lobby Congress on legislation to remove non-discrimination requirements relating to health care providers. (H.R. 2817, Protect Patient Access to Quality Health Professionals Act of 2013). Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 1647, H.R. 2835, Restoring Access to Medication Act). Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Lobby Congress on legislation to create a transparent and predictable review process for sunscreen ingredients (S. 2141/H.R. 4250 Sunscreen Innovation Act/ Public Law No: 113-195). Advocate on use and availability of health care data. Support legislation to exempt independent medical educational programs and materials from reporting under the Physician Payments Sunshine Act (Sunshine Act) (H.R. 5539)

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 460, Patients' Access to Treatments Act of 2013). Advocate for truth in advertising for health care providers (H.R. 1427, Truth in Healthcare Marketing Act of 2013). Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription (H.R. 3204, Drug Quality and Security Act/Public Law No: 113-54). Lobby Congress on legislation to remove non-discrimination requirements relating to health care providers. (H.R. 2817, Protect Patient Access to Quality Health Professionals Act of 2013). Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 1647, H.R. 2835, Restoring Access to Medication Act). Lobby Congress on legislation to create a transparent and predictable review process for sunscreen ingredients (S. 2141/H.R. 4250 Sunscreen Innovation Act). Lobby Congress on issues related to telemedicine. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Advocate on on use and availability of health care data.

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 460, Patients' Access to Treatments Act of 2013). Advocate for truth in advertising for health care providers (H.R. 1427, Truth in Healthcare Marketing Act of 2013). Lobby Members of Congress to join the Congressional Skin Cancer Caucus.Lobby Congress to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription (H.R. 3204, Drug Quality and Security Act/Public Law No: 113-54). Lobby Congress on legislation to remove non-discrimination requirements relating to health care providers. (H.R. 2817, Protect Patient Access to Quality Health Professionals Act of 2013). Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 1647, H.R. 2835, Restoring Access to Medication Act). Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2552/H.R. 4998, Medicare Advantage Participant Bill of Rights Act of 2014). Lobby Congress on legislation to create a transparent and predictable review process for sunscreen ingredients (S. 2141/H.R. 4250 Sunscreen Innovation Act). Lobby Congress on issues related to telemedicine (H.R. 5380, the Medicare Telehealth Parity Act). Advocate on on use and availability of health care data.

Lobby in support of FDA examination of the current classification of indoor tanning beds. Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 460, Patients' Access to Treatments Act of 2013). Advocate for truth in advertising for health care providers (H.R. 1427, Truth in Healthcare Marketing Act of 2013).Lobby Congress to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription (H.R. 3204, Drug Quality and Security Act/Public Law No: 113-54). Lobby Congress on legislation to remove non-discrimination requirements relating to health care providers. (H.R. 2817, Protect Patient Access to Quality Health Professionals Act of 2013). Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 1647, H.R. 2835, Restoring Access to Medication Act). Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2552/H.R. 4998, Medicare Advantage Participant Bill of Rights Act of 2014). Lobby Congress on legislation to create a transparent and predictable review process for sunscreen ingredients (S. 2141/H.R. 4250 Sunscreen Innovation Act). Lobby Congress on issues related to telemedicine.

Lobby in support of FDA examination of the current classification of indoor tanning beds. Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 460, Patients' Access to Treatments Act of 2013). Advocate for truth in advertising for health care providers (H.R. 1427, Truth in Healthcare Marketing Act of 2013).Lobby Congress to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription (H.R. 3204, Drug Quality and Security Act/Public Law No: 113-54). Lobby Congress on legislation to remove non-discrimination requirements relating to health care providers. (H.R. 2817, Protect Patient Access to Quality Health Professionals Act of 2013). Lobby Members of Congress to join the Congressional Skin Cancer Caucus Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 1647, H.R. 2835, Restoring Access to Medication Act). Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks.

Support legislation to enact medical liability reform (H.R. 1473, the Standard of Care Protection Act). Support inclusion of standard of care provisions similar to H.R. 1473 in S.2000/H.R. 4015.

Support legislation to enact medical liability reform (H.R. 1473, the Standard of Care Protection Act). Support inclusion of standard of care provisions similar to H.R. 1473 in S.2000/H.R. 4015.

Support legislation to enact medical liability reform (H.R. 1473, the Standard of Care Protection Act). Support inclusion of standard of care provisions similar to H.R. 1473 in S.2000/H.R. 4015.